CINVANTI
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 15 Nov 2023)
What this means for you
Registered since 06 Mar 2018. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87101607
- Registration number
- 5419060
- Mark type
- Stylized text
- Filed
- 12 Jul 2016
- Published for opposition
- 29 Nov 2016
- Registered
- 06 Mar 2018
- Attorney of record
- Beth M. Goldman
Goods and services
- Class 005 — Pharmaceuticals: Anti-emetic pharmaceutical preparations; pharmaceutical preparations for human and animal use for the treatment of pain, for gastrointestinal conditions, cancer, post-operative, chemotherapy-induced nausea and vomiting, autoimmune diseases, infectious diseases, inflammatory diseases, genetic diseases, cardiovascular diseases, orthopedic conditions, and for immunotherapy
Owner
- Heron Therapeutics, Inc., San Diego, CA, US
- Heron Therapeutics, Inc., Redwood City, CA, US
- Heron Therapeutics, Inc., Redwood City, CA, US
Prosecution history
- 15 Nov 2023 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 15 Nov 2023 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 14 Nov 2023 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 16 Aug 2023 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 16 May 2023 — TEAS SECTION 8 & 15 RECEIVED
- 06 Mar 2023 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 12 Mar 2018 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 12 Mar 2018 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 06 Mar 2018 — REGISTERED-PRINCIPAL REGISTER
- 30 Jan 2018 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 27 Jan 2018 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 18 Jan 2018 — STATEMENT OF USE PROCESSING COMPLETE
- 04 Jan 2018 — USE AMENDMENT FILED
- 17 Jan 2018 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 04 Jan 2018 — TEAS STATEMENT OF USE RECEIVED